Perrigo - 35 Year Stock Price History | PRGO

Historical daily share price chart and data for Perrigo since 1991 adjusted for splits and dividends. The latest closing stock price for Perrigo as of February 09, 2026 is 14.32.
  • The all-time high Perrigo stock closing price was 160.22 on April 14, 2015.
  • The Perrigo 52-week high stock price is 30.93, which is 116% above the current share price.
  • The Perrigo 52-week low stock price is 12.17, which is 15% below the current share price.
  • The average Perrigo stock price for the last 52 weeks is 22.18.
Perrigo Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2026 14.5669 13.8900 15.1700 13.7400 14.3200 2.87%
2025 22.4158 24.6077 27.8919 11.9951 13.9200 -42.79%
2024 26.5239 30.1895 31.0724 22.6662 24.3332 -16.92%
2023 30.3559 31.0171 35.7503 24.3348 29.2885 -2.47%
2022 32.6545 33.6200 37.2954 27.4141 30.0305 -9.78%
2021 36.6795 37.3026 41.5466 30.4711 33.2863 -10.95%
2020 42.4207 42.1578 49.9745 33.5449 37.3778 -11.97%
2019 40.2808 32.7160 46.4105 32.2071 42.4619 35.65%
2018 60.7243 71.7036 76.0687 29.4848 31.3023 -55.08%
2017 61.9983 68.5888 71.0302 52.5571 69.6810 5.58%
2016 82.5695 112.3310 117.5020 63.2921 65.9959 -42.14%
2015 135.2999 130.9590 160.2150 113.7340 114.0650 -13.18%
2014 118.6694 119.9880 132.6330 99.4959 131.3750 9.23%
2013 97.6578 83.3831 122.9430 77.5538 120.2700 47.95%
2012 83.4260 76.7637 93.6622 72.5419 81.2889 7.26%
2011 67.1860 49.4548 79.8171 49.0357 75.7901 54.17%
2010 44.7092 31.1773 52.7850 29.1915 49.1599 59.74%
2009 22.8027 24.2340 31.5559 14.5164 30.7755 24.28%
2008 26.5443 25.9017 32.3165 21.6227 24.7628 -7.15%
2007 16.2522 13.3014 27.5701 12.2984 26.6711 104.11%
2006 12.2301 11.3278 13.9676 10.8501 13.0672 17.29%
2005 11.5738 12.5588 14.6247 9.5805 11.1410 -12.73%
2004 13.9398 11.6493 17.0443 11.5686 12.7658 10.70%
2003 10.1829 9.0902 11.9963 7.8914 11.5319 30.41%
2002 8.6376 8.9082 10.6914 6.8922 8.8427 2.79%
2001 9.3753 6.0043 13.3114 5.9588 8.6026 42.73%
2000 5.1298 5.9134 6.5957 3.7527 6.0271 3.52%
1999 6.0330 6.4592 7.0051 5.2765 5.8224 -9.22%
1998 7.4334 10.2801 10.3711 5.4585 6.4137 -34.11%
1997 9.3606 6.5502 12.3726 6.5502 9.7343 46.57%
1996 7.9170 8.8245 10.3711 6.2773 6.6412 -23.16%
1995 8.9722 8.7336 10.0982 7.7329 8.6426 -5.00%
1994 13.2583 24.9271 24.9271 8.0058 9.0975 -63.50%
1993 18.5511 16.1025 24.9271 14.1011 24.9271 52.22%
1992 12.1158 10.3711 16.3755 8.6881 16.3755 51.26%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.971B $4.373B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $193.137B 21.57
EssilorLuxottica (ESLOY) France $140.784B 0.00
Stryker (SYK) United States $136.173B 26.12
Medtronic (MDT) Ireland $130.317B 18.06
Boston Scientific (BSX) United States $109.879B 24.30
Medline (MDLN) United States $62.231B 0.00
Lonza Group Ag (LZAGY) Switzerland $47.151B 0.00
ResMed (RMD) United States $40.201B 26.84
Agilent Technologies (A) United States $36.062B 22.85
GE HealthCare Technologies (GEHC) United States $36.041B 17.27
Koninklijke Philips (PHG) Netherlands $28.522B 18.63
Terumo (TRUMY) Japan $19.692B 22.25
Zimmer Biomet Holdings (ZBH) United States $17.783B 11.09
Insulet (PODD) United States $17.275B 53.62
Smith & Nephew SNATS (SNN) United Kingdom $14.896B 0.00
Baxter (BAX) United States $11.170B 9.02
Sunny Optical Technology (SNPTF) China $8.485B 0.00
Bio-Rad Laboratories (BIO) United States $7.955B 28.60
Demant (WILYY) Denmark $6.521B 0.00
Envista Holdings (NVST) United States $4.828B 24.47
Lantheus Holdings (LNTH) United States $4.324B 13.17
BillionToOne (BLLN) United States $4.229B 0.00
ICU Medical (ICUI) United States $3.749B 23.80
Shandong Weigao Medical Polymer (SHWGF) China $3.263B 0.00
Prestige Consumer Healthcare (PBH) United States $3.092B 14.59
Haemonetics (HAE) United States $2.681B 11.73
Neogen (NEOG) United States $2.308B 50.52
Phibro Animal Health (PAHC) United States $2.102B 18.52
QuidelOrtho (QDEL) United States $1.988B 12.78
LeMaitre Vascular (LMAT) United States $1.963B 39.52
AtriCure (ATRC) United States $1.836B 0.00
Curaleaf Holdings (CURLF) Canada $1.672B 0.00
Kestra Medical Technologies (KMTS) United States $1.564B 0.00
Green Thumb Industries (GTBIF) United States $1.452B 63.64
AdaptHealth (AHCO) United States $1.452B 21.02
Capricor Therapeutics (CAPR) United States $1.152B 0.00
Lumexa Imaging Holdings (LMRI) United States $1.092B 0.00
BioLife Solutions (BLFS) United States $1.090B 323.29
InMode (INMD) Israel $0.956B 10.80
Tilray Brands (TLRY) Canada $0.897B 0.00
Valneva SE (VALN) France $0.833B 0.00
Omeros (OMER) United States $0.801B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.795B 0.00
CeriBell (CBLL) United States $0.775B 0.00
VAREX IMAGING (VREX) United States $0.589B 15.95
Verano Holdings (VRNO) United States $0.469B 0.00
Brainsway (BWAY) Israel $0.442B 75.20
Cerus (CERS) United States $0.419B 0.00
Canopy Growth (CGC) Canada $0.402B 0.00
SNDL (SNDL) Canada $0.389B 0.00
Cresco Labs (CRLBF) United States $0.387B 0.00
Viemed Healthcare (VMD) United States $0.321B 25.61
SEMPERIT AG HLD (SEIGY) Austria $0.309B 0.00
Quanterix (QTRX) United States $0.288B 0.00
Evolus (EOLS) United States $0.275B 0.00
TriSalus Life Sciences (TLSI) United States $0.226B 0.00
Sanuwave Health (SNWV) United States $0.220B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Organigram Global (OGI) Canada $0.215B 0.00
High Tide (HITI) Canada $0.213B 0.00
TerrAscend (TSNDF) Canada $0.206B 0.00
Aurora Cannabis (ACB) Canada $0.203B 59.83
OraSure Technologies (OSUR) United States $0.202B 0.00
Utah Medical Products (UTMD) United States $0.200B 17.93
Accendra Health (ACH) United States $0.185B 1.85
Sanara MedTech (SMTI) United States $0.177B 0.00
Vireo Growth (VREOF) United States $0.163B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Apyx Medical (APYX) United States $0.156B 0.00
FitLife Brands (FTLF) United States $0.143B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.137B 0.00
Fonar (FONR) United States $0.116B 16.86
MacroGenics (MGNX) United States $0.114B 0.00
Jushi Holdings (JUSHF) United States $0.103B 0.00
Biote (BTMD) United States $0.100B 4.40
Exagen (XGN) United States $0.076B 0.00
ImmuCell (ICCC) United States $0.060B 25.54
Sharps Technology (STSS) United States $0.051B 0.00
Nephros (NEPH) United States $0.043B 30.92
Rockwell Medical (RMTI) United States $0.043B 0.00
Cytosorbents (CTSO) United States $0.042B 0.00
Veru (VERU) United States $0.038B 0.00
Modular Medical (MODD) United States $0.033B 0.00
United-Guardian (UG) United States $0.032B 16.30
Jin Medical (ZJYL) China $0.022B 0.00
Bonk (BNKK) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.013B 0.00
INLIF (INLF) China $0.009B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Agape ATP (ATPC) $0.002B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00